- Home
- SCSC vs MDXG Comparison
SCSC vs MDXG Comparison
Compare SCSC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCSC | MDXG |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.3M | 1.0B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCSC | MDXG |
|---|---|---|
| Price | $41.83 | $7.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $43.00 | $12.00 |
| AVG Volume (30 Days) | 156.6K | ★ 774.9K |
| Earning Date | 01-29-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 3.20 | 0.27 |
| Revenue | ★ $3,004,880,000.00 | $393,442,000.00 |
| Revenue This Year | $5.96 | $19.13 |
| Revenue Next Year | $5.06 | $2.11 |
| P/E Ratio | ★ $13.11 | $26.77 |
| Revenue Growth | N/A | ★ 14.77 |
| 52 Week Low | $28.75 | $5.79 |
| 52 Week High | $53.90 | $9.71 |
Technical Indicators
Market Signals| Indicator | SCSC | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 57.66 |
| Support Level | $40.06 | $6.62 |
| Resistance Level | $43.41 | $7.30 |
| Average True Range (ATR) | 1.18 | 0.24 |
| MACD | 0.14 | 0.06 |
| Stochastic Oscillator | 58.21 | 91.33 |
Price Performance
Historical ComparisonAbout SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.